Journal Article Summary
The article investigates the variability in response to two common antiplatelet medications, aspirin and clopidogrel, which are often prescribed to patients with coronary artery disease. Understanding this variability is crucial because some patients may not respond adequately to these treatments, potentially leading to recurrent cardiovascular events. Identifying factors that contribute to this resistance can help improve patient outcomes and guide more effective treatment strategies.
The authors conducted a thorough review of existing literature published between 1996 and 2007, focusing on studies related to aspirin and clopidogrel resistance. They found that certain characteristics, such as being female, older age, and lower hemoglobin levels, were associated with reduced effectiveness of aspirin. Additionally, patients with type-2 diabetes were more likely to have an inadequate response to clopidogrel. The review highlighted the need for further research to establish standardized methods for assessing response variability and to better understand the implications of these findings for patient care.
Despite the insights gained, the study has limitations, including the reliance on previously published studies, which may vary in quality and methodology. This variability in research could affect the reliability of the findings. Patients should discuss their individual responses to antiplatelet therapy with their healthcare providers, especially if they have risk factors like diabetes or are experiencing recurrent cardiovascular issues. Open communication can help ensure that patients receive the most appropriate and effective treatment for their conditions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ferguson Angela D., Dokainish Hisham, Lakkis Nasser. Aspirin and Clopidogrel Response Variability. Texas Heart Institute Journal 2008. PMID: 18941611. PMCID: PMC2565550.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
